LENZ

LENZ Therapeutics

63 hedge funds and large institutions have $186M invested in LENZ Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$8.87M
2 +$4.7M
3 +$4.49M
4
BlackRock
BlackRock
New York
+$4.31M
5
EC
EcoR1 Capital
California
+$3M

Top Sellers

1 -$8.24M
2 -$5.05M
3 -$4.69M
4
RSCM
Rock Springs Capital Management
Maryland
-$2.58M
5
Morgan Stanley
Morgan Stanley
New York
-$1.21M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$41.2M
2
$36.9M
3
$13.8M
4
$9.13M
5
$8.64M
6
$8.22M
7
$7.99M
8
$6.4M
9
$6.13M
10
$5.39M
11
$5.22M
12
$3.62M
13
$3.58M
14
$3.57M
15
$2.87M
16
$2.83M
17
$2.68M
18
$2.13M
19
$2.07M
20
$1.66M
21
$1.64M
22
$1.53M
23
$1.3M
24
$1.26M
25
$1.23M